1. Menyhart O, Kothalawala WJ, Győrffy B. A gene set enrichment analysis for cancer hallmarks. J Pharm Anal. 2025. május;15(5):101065.
2. Guedes J, Woldmar N, Szasz AM, Wieslander E, Pawłowski K, Horvatovich P, és mtsai. A perspective on integrating digital pathology, proteomics, clinical data and AI analytics in cancer research. J Proteomics. 2025. szeptember 15.;320:105493.
3. Ungvari Z, Fekete M, Fekete JT, Grosso G, Ungvari A, Győrffy B. Adherence to the Mediterranean diet and its protective effects against colorectal cancer: a meta-analysis of 26 studies with 2,217,404 participants. GeroScience. 2025. február;47(1):1105–21.
4. Caruso A, Accattatis FM, Giordano C, Gelsomino L, Del Console P, Fiorita MF, és mtsai. Adipocyte/Tumor cell crosstalk via IGF-1/TXNIP axis promotes malignancy and endocrine resistance in breast cancer. Cell Commun Signal CCS. 2025. június 3.;23(1):262.
5. Ungvari Z, Fekete M, Varga P, Lehoczki A, Munkácsy G, Fekete JT, és mtsai. Association between red and processed meat consumption and colorectal cancer risk: a comprehensive meta-analysis of prospective studies. GeroScience. 2025. június;47(3):5123–40.
6. Sawada Y, Kikugawa T, Onishi T, Arai O, Iio H, Miura N, Gyorffy B. és mtsai. CTHRC1 promotes bone metastasis in prostate cancer. Int J Cancer. 2025. június 21.;
7. Ungvari Z, Fekete M, Buda A, Lehoczki A, Fekete JT, Varga P, és mtsai. Depression increases cancer mortality by 23-83%: a meta-analysis of 65 studies across five major cancer types. GeroScience. 2025. május 2.;
8. Callari M, Dugo M, Barreca M, Győrffy B, Galbardi B, Vigano L, és mtsai. Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies. Nat Commun. 2025. március 4.;16(1):2195.
9. Nemeth Z, Eros K, Munkacsy G, Koller A. Differential Gene and Protein Expressions Responsible for Vasomotor Signaling Provide Mechanistic Bases for the Opposite Flow-Induced Responses of Pre- and Post-Circle of Willis Arteries. Life Basel Switz. 2025. május 26.;15(6):856.
10. Olah C, Mairinger F, Wessolly M, Joniau S, Spahn M, Kruithof-de Julio M, Gyorffy B. és mtsai. Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers. Prostate Cancer Prostatic Dis. 2025. szeptember;28(3):773–81.
11. Müller D, Győrffy B. EpigenPlot: An interactive web platform for DNA methylation-based biomarker and drug target discovery in colorectal cancer. Br J Pharmacol. 2025. április;182(7):1452–65.
12. Ungvari Z, Fekete M, Varga P, Munkácsy G, Fekete JT, Lehoczki A, és mtsai. Exercise and survival benefit in cancer patients: evidence from a comprehensive meta-analysis. GeroScience. 2025. június;47(3):5235–55.
13. Munkácsy G, Santarpia L, Győrffy B. Exploring immune activation patterns in HER2-low and HER2-ultralow breast cancer subtypes. The Oncologist. 2025. június 4.;30(6):oyaf081.
14. Li X, Rossing M, Moisés da Silva A, Bose M, Gudjónsson T, Benada J, Szallasi Z és mtsai. G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor. JCI Insight. 2025. június 9.;10(11):e186747.
15. Kilim O, Olar A, Biricz A, Madaras L, Pollner P, Szállási Z, és mtsai. Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction. MedRxiv Prepr Serv Health Sci. 2024. június 3.;2024.06.01.24308293.
16. Sanvicente A, Nieto-Jiménez C, Morafraile EC, Díaz-Tejeiro C, Barberán VG, Segura PP, Gyorffy B és mtsai. Identification of Deregulated Proteins in Mutated BRCA1/2 Breast and Ovarian Cancers for Vectorized Biologics. Cancers. 2025. július 1.;17(13):2208.
17. Ungvari Z, Fekete M, Varga P, Fekete JT, Lehoczki A, Buda A, és mtsai. Imbalanced sleep increases mortality risk by 14-34%: a meta-analysis. GeroScience. 2025. június;47(3):4545–66.
18. Ungvari Z, Fekete M, Varga P, Fekete JT, Buda A, Szappanos Á, és mtsai. Impact of adherence to the Mediterranean diet on stroke risk. GeroScience. 2025. június;47(3):3565–81.
19. P Shanmugam S, Zhou Y, Stelter I, Hanlon T, Bekele RT, Bellmunt J, Szallasi Z, és mtsai. Impact of DNA repair deficiency on sensitivity to antibody-drug conjugate (ADC) payloads in bladder cancer. Bladder Cancer Amst Neth. 2025;11(1):23523735251317865.
20. Nieto-Jiménez C, Garcia-Lorenzo E, Diaz-Tejeiro C, Paniagua-Herranz L, Sanvicente A, Doger B, Munkacsy Gy, Gyorffy B és mtsai. In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations. Sci Rep. 2025. május 22.;15(1):17832.
21. Ungvari Z, Fekete M, Lehoczki A, Munkácsy G, Fekete JT, Zábó V, és mtsai. Inadequate sleep increases stroke risk: evidence from a comprehensive meta-analysis of incidence and mortality. GeroScience. 2025. június;47(3):4679–95.
22. Ocana A, Pandiella A, Privat C, Bravo I, Luengo-Oroz M, Amir E, Gyorffy B és mtsai. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach. Biomark Res. 2025. március 14.;13(1):45.
23. Major E, Lin KH, Lee SC, Káldi K, Győrffy B, Tigyi GJ, és mtsai. LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10. Acta Pharmacol Sin. 2025;46(1):222–30.
24. Bartha Á, Weltz B, Betancourt LH, Gil J, Pinto de Almeida N, Bianchini G, és mtsai. Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT. J Proteome Res. 2025. június 6.;24(6):3117–28.
25. Fekete JT, Győrffy B. MetaAnalysisOnline.com: Web-Based Tool for the Rapid Meta-Analysis of Clinical and Epidemiological Studies. J Med Internet Res. 2025. március 6.;27:e64016.
26. Fichó E, Pancsa R, Magyar C, Kalman ZE, Schád É, Németh BZ, Dobson L, Tusnady G és mtsai. MFIB 2.0: a major update of the database of protein complexes formed by mutual folding of the constituting protein chains. Nucleic Acids Res. 2025;53(D1):D487–94.
27. Kim Y, Doma V, Çakır U, Kuras M, Betancourt LH, Pla I, Szasz AM és mtsai. Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies. Cancer. 2025. július 1.;131(13):e35897.
28. Ungvari Z, Fekete M, Buda A, Lehoczki A, Fekete JT, Munkácsy G, és mtsai. No detectable impact of short-term treatment delays on lung cancer survival. GeroScience. 2025. május 7.;
29. Tóth E, Posta M, Györffy B, Oravecz O, Farkas E, Balogh A, és mtsai. Novel proteomics biomarkers of recurrent pregnancy loss reflect the dysregulation of immune interactions at the maternal-fetal interface. Front Immunol. 2025;16:1621168.
30. Ungvari Z, Menyhart O, Lehoczki A, Fekete M, Fazekas-Pongor V, Ocana A, és mtsai. NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions. GeroScience. 2025. június 19.;
31. Sziklavari Z, Hammoudeh S, Petrone AM, Stange S, Orban K, Fekete JT, és mtsai. Outcomes of Vacuum-Assisted Closure in Patients with Empyema Thoracis: A 10-Year Experience. Ann Thorac Surg. 2025. június;119(6):1206–12.
32. Ungvari Z, Fekete M, Varga P, Lehoczki A, Fekete JT, Ungvari A, és mtsai. Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25-57% elevation in risk. GeroScience. 2025. június;47(3):3343–64.
33. Ungvari Z, Menyhart O, Lehoczki A, Fekete M, Bianchini G, Győrffy B. PCSK9 expression and cancer survival: a prognostic biomarker at the intersection of oncology and geroscience. GeroScience. 2025. június 27.;
34. Sztupinszki Z, Fiam R, Pipek O, Diossy M, Börcsök J, Prosz A, Szallasi Z és mtsai. Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumors. NPJ Precis Oncol. 2025. június 20.;9(1):200.
35. Tian L, Jiao X, Wang C, Li D, Ertel A, Achinger-Kawecka J, Gyorffy B és mtsai. PPARγ acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding. Oncogene. 2025. szeptember;44(37):3476–92.
36. Lehoczki A, Menyhart O, Andrikovics H, Fekete M, Kiss C, Mikala G, és mtsai. Prognostic impact of a senescence gene signature in multiple myeloma. GeroScience. 2025. június;47(3):5025–37.
37. Ungvari Z, Bartha Á, Ungvari A, Fekete M, Bianchini G, Győrffy B. Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types. GeroScience. 2025. június;47(3):4413–27.
38. Kuras M, Betancourt LH, Hong R, Szadai L, Rodriguez J, Horvatovich P, Szasz AM és mtsai. Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma. Cancers. 2025. február 27.;17(5):832.
39. Ungvari Z, Fekete M, Buda A, Lehoczki A, Munkácsy G, Scaffidi P, és mtsai. Quantifying the impact of treatment delays on breast cancer survival outcomes: a comprehensive meta-analysis. GeroScience. 2025. június 10.;
40. Börcsök J, Gopaul D, Devesa-Serrano D, Mooser C, Jonsson N, Cagiada M, Szallasi Z és mtsai. Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer. J Clin Invest. 2025;135(16):e186688.
41. Dobson L, Tusnády GE, Tompa P. Regularly updated benchmark sets for statistically correct evaluations of AlphaFold applications. Brief Bioinform. 2025. március 4.;26(2):bbaf104.
42. Ungvári Z, Menyhart O, Ocana A, Fekete M, Lehoczki A, Győrffy B. Senescence-associated gene signatures predict survival in lung cancer: a multi-cohort analysis. GeroScience. 2025. szeptember 27.;
43. Ungvari Z, Ungvari A, Fekete M, Kiss C, Győrffy B. Senescence-related genes as prognostic indicators in breast cancer survival. GeroScience. 2025. június;47(3):2995–3006.
44. Ungvari Z, Fekete M, Lehoczki A, Munkácsy G, Fekete JT, Zábó V, és mtsai. Sleep disorders increase the risk of dementia, Alzheimer’s disease, and cognitive decline: a meta-analysis. GeroScience. 2025. június;47(3):4899–920.
45. Raab M, Győrffy B, Peña-Llopis S, Fietz D, Kressin M, Kolaric M, és mtsai. Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models. Cancer Commun Lond Engl. 2025;45(8):966–70.
47. Salman ND, Hanker LC, Győrffy B, Bartha Á, Proppe L, Götte M. The Prognostic Value of the Hedgehog Signaling Pathway in Ovarian Cancer. Int J Mol Sci. 2025. június 19.;26(12):5888.
48. Fekete M, Varga P, Ungvari Z, Fekete JT, Buda A, Szappanos Á, és mtsai. The role of the Mediterranean diet in reducing the risk of cognitive impairement, dementia, and Alzheimer’s disease: a meta-analysis. GeroScience. 2025. június;47(3):3111–30.
49. Bajtai E, Kiss C, Bakos É, Langó T, Lovrics A, Schád É, és mtsai. Therapy-induced senescence is a transient drug resistance mechanism in breast cancer. Mol Cancer. 2025. május 1.;24(1):128.
50. Tusnády GE, Gerdán C. TmDet 4.0: determining membrane orientation of transmembrane proteins from 3D structure. Nucleic Acids Res. 2025. július 7.;53(W1):W542–6.
51. Ungvari Z, Fekete M, Fekete JT, Lehoczki A, Buda A, Munkácsy G, és mtsai. Treatment delay significantly increases mortality in colorectal cancer: a meta-analysis. GeroScience. 2025. június;47(3):5337–53.
52. Raab M, Gasimli K, Győrffy B, Peña-Llopis S, Becker S, Sanhaji M, és mtsai. Truncated DAPK Variants Restore Tumor Suppressor Activity and Synergize with Standard Therapies in High-Grade Serous Ovarian Cancer. Cancers. 2025. június 8.;17(12):1910.
53. Pla I, Szabolcs BL, Péter PN, Ujfaludi Z, Kim Y, Horvatovich P, Bartha A, Szasz AM, Gyorffy B és mtsai. Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes. Int J Dermatol. 2025. május;64(5):870–81.
54. Kovács SA, Kovács T, Lánczky A, Paál Á, Hegedűs ZI, Sayour NV, és mtsai. Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti-PD1 resistance in skin cutaneous melanoma. Br J Pharmacol. 2025;182(16):3903–22.
55. Nava V, Dar JY, De Santis V, Fehlinger L, Pasqualini J, Adekolurejo OA, Figler A és mtsai. Zooming in the plastisphere: the ecological interface for phytoplankton-plastic interactions in aquatic ecosystems. Biol Rev Camb Philos Soc. 2025. április;100(2):834–54.